Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncotarget. 2016 May 10;7(19):27552-66. doi: 10.18632/oncotarget.8487.

Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.

Huang B1,2,3, Yin M4,5, Li X6,7, Cao G4, Qi J4, Lou G8, Sheng S9,10, Kou J4, Chen K2,3,10,11,12, Yu B4.

Author information

1
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA.
2
Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA.
3
Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Detroit, Michigan, USA.
4
State Key Laboratory of Natural Products and Jiangsu Key Laboratory of Traditional Chinese Medicine (TCM) Evaluation and Translational Research, Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, China.
5
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
6
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
7
Yale Stem Cell Center, Yale University, New Haven, Connecticut, USA.
8
Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Harbin Medical University, Harbin, China.
9
Department of Pathology, Wayne State University, Detroit, Michigan, USA.
10
Tumor Biology and Microenvironment Program, Barbara Ann Karmanos Cancer Center and Department of Oncology, Wayne State University, Detroit, Michigan, USA.
11
Department of Immunology and Microbiology, Wayne State University, Detroit, Michigan, USA.
12
Mucosal Immunology Studies Team, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Abstract

Epithelial ovarian carcinomas (EOC) cause more mortality than any other cancer of the female reproductive system. New therapeutic approaches to reduce EOC mortality have been largely unsuccessful due to the poor understanding of the mechanisms underlying EOC proliferation and metastasis. Progress in EOC treatment is further hampered by a lack of reliable prognostic biomarkers for early risk assessment. In this study, we identify that Migration-Inducting Gene 7 (MIG-7) is specifically induced in human EOC tissues but not normal ovaries or ovarian cyst. Ovarian MIG-7 expression strongly correlated with EOC progression. Elevated MIG-7 level at the time of primary cytoreductive surgery was a strong and independent predictor of poor survival of EOC patients. Cell and murine xenograft models showed that MIG-7 was required for EOC proliferation and invasion, and MIG-7 enhanced EOC-associated angiogenesis by promoting the expression of vascular endothelial growth factor. Inhibiting MIG-7 by RNA interference in grafted EOC cells retarded tumor growth, angiogenesis and improved host survival, and suppressing MIG-7 expression with a small molecule inhibitor D-39 identified from the medicinal plant Liriope muscari mitigated EOC growth and invasion and specifically abrogated the expression of vascular endothelial growth factor. Our data not only reveal a critical function of MIG-7 in EOC growth and metastasis and support MIG-7 as an independent prognostic biomarker for EOC, but also demonstrate that therapeutic targeting of MIG-7 is likely beneficial in the treatment of EOC.

KEYWORDS:

Migration-Inducting Gene 7; angiogenesis; biomarker; epithelial ovarian cancer; prognosis

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Impact Journals, LLC Icon for PubMed Central
    Loading ...
    Support Center